跳至主要内容
临床试验/NCT03628495
NCT03628495Unknown不适用

Effectiveness of a Combined Adequate Pressure and Silicone Intervention in Comparison With Conventional Pressure Therapy for Hypertrophic Scar Treatment: a Randomized Controlled Trial

The Hong Kong Polytechnic University0 个研究点目标入组 72 人开始时间: 2018年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
72
主要终点
Change from baseline HS thickness at 6 months

研究概览

简要总结

Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatments HS, yet the effectiveness of the combination of these two treatments through an RCT trial has not been established yet. This study aims to examine the effectiveness of the combination of adequate pressure therapy and silicone gel sheeting implemented by Smart Scar Care Pad (SSCP) + Smart Pressure Monitored Suit (SPMS) versus conventional Pressure Garment (PG in the management of severe HS in adult. It is hypothesized that the combination of adequate pressure therapy and silicone gel sheeting will demonstrate its superiority in improving scar parameters than conventional pressure garment therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

The ultrasound data will be processed and the data will be analysed by analysts who are blinded.

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • The Vancouver Scar Scale (VSS) will be used to screen candidates for the study.10 Isolated scars with a total score of 4 or higher and the score of each item equal to or greater than 1 will be included.
  • The scar size should also reach 2*2 cm2 or above to allow adequate area for assessment tool attachement.
  • Consenting adult's age between 19 to 60 years old who is able to provide written consent, cooperative, and good compliance with treatment.

排除标准

  • the HS area have an open wound or infection;
  • the HS have been treated with steroid injections or other intervention (such as traditional Chinese medicine or laser therapy) prior to the study;
  • the patients have a medical condition that might affect wound healing (e.g., diabetes mellitus or another serious medical problem);
  • the patients with comorbidities that might affect their compliance to treatment: such as severe scar contracture at adjacent area that might be scheduled for reconstructive surgery.

研究组 & 干预措施

SSCP + SPMS

Experimental

干预措施: compression (Device)

SSCP + SPMS

Experimental

干预措施: occlusion (Device)

PG

Active Comparator

干预措施: compression (Device)

结局指标

主要结局

Change from baseline HS thickness at 6 months

时间窗: at baseline, one and six month after treatment

HS thickness measured by the Diagnostic Ultrasound System

次要结局

  • Change from baseline HS pliability at 6 months(at baseline, one and six month after treatment)
  • Change from baseline HS hydration at 6 months(at baseline, one and six month after treatment)
  • Change from baseline HS color at 6 months(at baseline, one and six month after treatment)
  • Itchiness(at baseline, one and six month after treatment)
  • QoL(at baseline, one and six month after treatment)

研究者

申办方类型
Other
责任方
Sponsor

相似试验